We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Molecular Manipulation Induces Skin Cells to Produce Hair

By LabMedica International staff writers
Posted on 22 Aug 2017
Working with mouse skin cells, researchers have generated hair-producing follicles from newborn and adult cells and traced the molecular pathways that control their development.

Investigators at the University of Southern California (Los Angeles, USA) were particularly interested in determining whether adult skin cells could be transformed into hair-producing follicles. More...
Towards this end, they began with an in depth imaging analysis of skin cells from newborn mice during the process of forming three-dimensional, hair-producing organoids.

Observations described in the August 10, 2017, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences revealed that skin cells from newborn mice formed organoids by transitioning through six distinct phases: 1) dissociated cells; 2) aggregated cells; 3) cysts; 4) coalesced cysts; 5) layered skin; and 6) skin with follicles, which robustly produced hair after being transplanted onto the back of a host mouse. These physical manifestations were driven at the molecular level by the sequential expression of adhesion molecules, growth factors, Wnt signaling proteins, and matrix metalloproteinases (MMPs).

In contrast, skin cells from adult mice formed small aggregates, but then development stalled when grown in vitro cultures. Findings from the newborn cells study enabled the investigators to develop a strategy to restore morphological transitions and rescue the hair-forming ability of adult organoids: (i) continuous PKC (Protein kinase C) inhibition and (ii) timely supply of the growth factors IGF (Insulin-like growth factor) and VEGF (Vascular endothelial growth factor), Wnts, and MMPs.

By providing the correct molecular and genetic cues in the proper sequence, the investigators were able to stimulate adult organoids to continue their development and eventually produce hair. Ultimately, adult organoids produced about 40% as much hair as the newborn organoids.

"Normally, many aging individuals do not grow hair well, because adult cells gradually lose their regenerative ability," said senior author Dr. Cheng-Ming Chuong, professor of pathology at the University of Southern California. "With our new findings, we are able to make adult mouse cells produce hair again. In the future, this work can inspire a strategy for stimulating hair growth in patients with conditions ranging from alopecia to baldness."

Related Links:
University of Southern California


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.